ArticleCHEST pulmonary2026
Effects of Clot Burden and Distribution on Pulmonary Embolism Response Team Patients.
Article in CHEST pulmonary, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The importance of clot burden on CT scan in determining outcomes in patients with pulmonary embolism (PE) is poorly studied. We sought to analyze the association between PE clot burden and outcomes in patients who underwent a PE response team activation. Research Question: Does clot burden and distribution impact clinical outcomes in patients with PE? Study Design and Methods: We performed a retrospective review of patients with PE response team activation between January 2021 and May 2022. Clot obstruction was scored according to percentage of obstructed surface of each central and peripheral vessel using the Mastora scoring system. Based on the median percentage of peripheral and central obstruction, we categorized patients into the following 4 groups: high peripheral only, high central only, high peripheral and central, and neither high peripheral nor high central clot obstruction. Outcomes included ICU transfer, need for pressors within 24 hours, cardiac arrest during admission, in-hospital mortality, and 30-day mortality. Significant associations were analyzed in a multivariable logistic regression model while controlling for potential confounders. Results: A total of 140 patients met inclusion criteria and were analyzed. Most patients (n = 113, 81%) were treated with anticoagulant therapy alone, whereas 27 patients (19%) received mechanical thrombectomy plus anticoagulant therapy. Patients in the high peripheral only group had increased odds of suffering cardiac arrest during admission (OR, 4.17; 95% CI, 1.06-16.35). The association persisted in multivariable logistic regression (OR, 20.85; 95% CI, 2.85-152.55). Interpretation: The results of this study show that patients with high peripheral only clot burden have an increased risk of cardiac arrest during hospitalization for incident PE. As such, clot burden and location may be indicators to guide selection of PE-directed therapy. Future studies confirming our findings are warranted.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.